Navigation Links
Expanding drug development horizons: Receptor behaviors observed in living cell membranes
Date:2/7/2011

Kyoto, Japan -- Unprecedented single molecule imaging movies of living cell membranes, taken by a research team based at Kyoto University and the University of New Mexico, have clarified a decades-old enigma surrounding receptor molecule behaviors. The results, appearing in the latest issue of the Journal of Cell Biology, promise to open the door to new possibilities for drug development.

The work focuses on G protein-coupled receptors (GPCRs), a class of molecules in cell membranes that comprise the largest superfamily in the human genome. In spite of being the focus of roughly half of modern drug development due to their key role in signaling across the membrane, until now it has not been well understood how GPCRs relay signals from the outside world into cells' interiors.

For over 15 years, debate regarding GPCRs' signaling mechanisms has centered on whether these molecules work alone (as monomers) or in pairs (dimers). Using formyl-peptide receptors (FPRs) as a model GPCR, the research team found that the two views are both partially correct.

"By developing a super-quantitation single-molecule imaging method, in which GPCR molecules are inspected one by one in living cell membranes," explained Rinshi Kasai of Kyoto University's Institute for Integrated Cell-Material Sciences (iCeMS) and lead author of the paper, "we are now able to actually 'see' that each individual FPR molecule moves around in the cell membrane, endlessly interconverting between monomers and dimers with different partners, completing each cycle within a quarter of a second."

According to iCeMS Professor Akihiro Kusumi, "We obtained a parameter called the dissociation constant, which will allow us to predict numbers of monomers and dimers if the total number of GPCRs in a cell is known. The ability of scientists to obtain such key numbers will be essential for understanding GPCR signaling, as well as defects leading to diseases from the neuronal to the immune systems. The implications for drug design, blocking signal amplification by monomer-dimer interconversion, are profoundly important."

The research team, funded in part by the Japan Science and Technology Agency (JST) and the Japanese education ministry MEXT, anticipates that their findings will have a broad impact on the further study of signal transduction in the cell membrane and conceptual and methodological development for drug discovery.


'/>"/>

Contact: Yutaka Iijima
yutaka-iijima@icems.kyoto-u.ac.jp
Institute for Integrated Cell-Material Sciences, Kyoto University
Source:Eurekalert

Related biology technology :

1. Safe and Secure TV Channel Expanding Programming and Revenue Agreements for 2011 with Pentagons Military News Channel and other Security Industry Leaders
2. Oridion Signs New Distributor Agreement With IMI Expanding its Presence in the Japanese Market
3. San Diego Region Awarded $4 Million Workforce Development Grant to Support Expanding Biofuels Industry
4. No Economic Slowdown for Expanding U.S. Medical Manufacturer
5. SynCo Bio Partners Increases its Capacities by Expanding its Quality Team
6. Expanding Indianas Breakthroughs in Health Information Technology (Exibhit Indiana): Initiative to Advance the States Health IT National Leadership and Assets Launched to Bring More Awareness to Sector
7. Biomedical Sciences Companies Expanding in Asia Invested More Than US$500 Million in Singapore
8. Robust Annual Growth Through 2012 in the Age-Related Macular Degeneration Market Will Be Driven by Expanding Use of Lucentis in Europe
9. Rapidly Expanding Ohio Bioscience Industry Drives New Workforce Training Program
10. ViroPharma Enhances Leadership to Support Global Growth and Expanding Business
11. ALS Therapy Development Institute Appoints Anil Godhwani to Board of Directors
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/22/2017)... Bahama (PRWEB) , ... March 21, 2017 , ... Okyanos ... educational seminar as part of their live events series, “Stem Cell Therapy: The Next ... cell facility under the 2013 Stem Cell Research and Therapy Act, Okyanos ...
(Date:3/22/2017)... ... March 21, 2017 , ... Benchworks CEO ... Executive Officer Forum on March 23-24 in San Diego. The event is a ... diagnostic industries. , Benchworks Vice President Christian Meyer will also participate in the ...
(Date:3/22/2017)... ... , ... The Conference Forum has announced the launch of the 5th Annual ... 2017, at the Colonnade Hotel in Boston, MA. The CMO Summit is the only ... and support. , “The Chief Medical Officer faces a unique set of challenges at ...
(Date:3/22/2017)... and CARDIFF, UK (PRWEB) , ... March 21, 2017 , ... ... flow and tissue oxygenation, is being explored as a way to track the brain’s ... study on tonic pain activation by cold pressor test ,” published today in the ...
Breaking Biology Technology:
(Date:2/26/2017)... , Feb. 25, 2017  Securus Technologies, a ... solutions for public safety, investigation, corrections and monitoring, ... and Reentry. "Too often, too many ... and county jails are trying to tackle this ... and friends and family members. While significant steps are ...
(Date:2/21/2017)... and PORTLAND, Ore. , ... and the Avamere Family of Companies (Avamere Health Services, ... announced a six-month research study that will apply the ... eldercare at senior living and health centers. By analyzing ... hopes to gain insights into physical and environmental conditions, ...
(Date:2/14/2017)... N.C. , Feb. 14, 2017  Wake Forest ... M.D., as its new chief executive officer (CEO). Freischlag ... CEO John D. McConnell , M.D., who last ... position at the Medical Center, after leading it since ... the full scope of Wake Forest Baptist,s academic health ...
Breaking Biology News(10 mins):